About Protein ENL
Protein ENL (MLLT1) is a protein
from Homo sapiens identified by UniProt accession
Q03111, 559 residues long.
MolForge cross-references it against 0 known binders and
144 disease associations.
Target properties
| Protein name | Protein ENL |
| UniProt accession | Q03111 |
| Gene | MLLT1 |
| Organism | Homo sapiens |
| Length | 559 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (144)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.50
- acute myeloid leukemia · score 0.39
- acute lymphoblastic leukemia · score 0.38
- B-cell acute lymphoblastic leukemia · score 0.37
- lysosomal storage disease · score 0.35
- T-cell acute lymphoblastic leukemia · score 0.28
- blastic plasmacytoid dendritic cell neoplasm · score 0.28
- body height · score 0.27
- Global developmental delay · score 0.26
- Hypertelorism · score 0.26
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q03111-F1 | alphafold | PREDICTED | 64.66 | — |
Amino-acid sequence (559 residues)
MDNQCTVQVR LELGHRAQLR KKPTTEGFTH DWMVFVRGPE QCDIQHFVEK VVFWLHDSFP KPRRVCKEPP YKVEESGYAG FIMPIEVHFK NKEEPRKVCF TYDLFLNLEG NPPVNHLRCE KLTFNNPTTE FRYKLLRAGG VMVMPEGADT VSRPSPDYPM LPTIPLSAFS DPKKTKPSHG SKDANKESSK TSKPHKVTKE HRERPRKDSE SKSSSKELER EQAKSSKDTS RKLGEGRLPK EEKAPPPKAA FKEPKMALKE TKLESTSPKG GPPPPPPPPP RASSKRPATA DSPKPSAKKQ KKSSSKGSRS APGTSPRTSS SSSFSDKKPA KDKSSTRGEK VKAESEPREA KKALEVEESN SEDEASFKSE SAQSSPSNSS SSSDSSSDSD FEPSQNHSQG PLRSMVEDLQ SEESDEDDSS SGEEAAGKTN PGRDSRLSFS DSESDNSADS SLPSREPPPP QKPPPPNSKV SGRRSPESCS KPEKILKKGT YDKAYTDELV ELHRRLMALR ERNVLQQIVN LIEETGHFNV TNTTFDFDLF SLDETTVRKL QSCLEAVAT
Explore Protein ENL with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets